Helicobacter pylori bacteria is considered to be the main cause of gastric cancer, with the infection rate particularly high ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plan to submit a UK Marketing Authorisation Application (MAA) for Talicia for treatment ...

Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions. FD is classified as a disorder of gut-brain interaction (DGBI), characterized by ...

Curative Health Insurance Company is proud to have been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2025. This year's list shines a spotlight on businesses ...

RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA's2 new fast-track approval process, referencing FDA approval, with potential UK approval ...